Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization

Paul Fredrickson, Mona Boules, Sally Yerbury, Elliott Richelson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Neurotensin is a tridecapeptide that participates in regulation of dopaminergic pathways implicated in nicotine addiction. Previously, we showed that one of our brain-penetrating neurotensin analogs, NT69L, blocks nicotine-induced locomotor sensitization. The present work demonstrates that NT69L blocks both the initiation and the expression of sensitization. In addition chronic NT69L administration blocked the acute effects of nicotine on norepinephrine and serotonin in prefrontal cortex.

Original languageEnglish (US)
Pages (from-to)245-248
Number of pages4
JournalBrain Research
Volume979
Issue number1-2
DOIs
StatePublished - Jul 25 2003

Fingerprint

Neurotensin
Nicotine
Prefrontal Cortex
Serotonin
Norepinephrine
Brain
neurotensin 69L

Keywords

  • Neurotensin
  • Nicotine
  • NT69L
  • Sensitization

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. / Fredrickson, Paul; Boules, Mona; Yerbury, Sally; Richelson, Elliott.

In: Brain Research, Vol. 979, No. 1-2, 25.07.2003, p. 245-248.

Research output: Contribution to journalArticle

Fredrickson, Paul ; Boules, Mona ; Yerbury, Sally ; Richelson, Elliott. / Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. In: Brain Research. 2003 ; Vol. 979, No. 1-2. pp. 245-248.
@article{a35e22b1231b48ff9613f99eff79a188,
title = "Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization",
abstract = "Neurotensin is a tridecapeptide that participates in regulation of dopaminergic pathways implicated in nicotine addiction. Previously, we showed that one of our brain-penetrating neurotensin analogs, NT69L, blocks nicotine-induced locomotor sensitization. The present work demonstrates that NT69L blocks both the initiation and the expression of sensitization. In addition chronic NT69L administration blocked the acute effects of nicotine on norepinephrine and serotonin in prefrontal cortex.",
keywords = "Neurotensin, Nicotine, NT69L, Sensitization",
author = "Paul Fredrickson and Mona Boules and Sally Yerbury and Elliott Richelson",
year = "2003",
month = "7",
day = "25",
doi = "10.1016/S0006-8993(03)02895-6",
language = "English (US)",
volume = "979",
pages = "245--248",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization

AU - Fredrickson, Paul

AU - Boules, Mona

AU - Yerbury, Sally

AU - Richelson, Elliott

PY - 2003/7/25

Y1 - 2003/7/25

N2 - Neurotensin is a tridecapeptide that participates in regulation of dopaminergic pathways implicated in nicotine addiction. Previously, we showed that one of our brain-penetrating neurotensin analogs, NT69L, blocks nicotine-induced locomotor sensitization. The present work demonstrates that NT69L blocks both the initiation and the expression of sensitization. In addition chronic NT69L administration blocked the acute effects of nicotine on norepinephrine and serotonin in prefrontal cortex.

AB - Neurotensin is a tridecapeptide that participates in regulation of dopaminergic pathways implicated in nicotine addiction. Previously, we showed that one of our brain-penetrating neurotensin analogs, NT69L, blocks nicotine-induced locomotor sensitization. The present work demonstrates that NT69L blocks both the initiation and the expression of sensitization. In addition chronic NT69L administration blocked the acute effects of nicotine on norepinephrine and serotonin in prefrontal cortex.

KW - Neurotensin

KW - Nicotine

KW - NT69L

KW - Sensitization

UR - http://www.scopus.com/inward/record.url?scp=0038383852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038383852&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(03)02895-6

DO - 10.1016/S0006-8993(03)02895-6

M3 - Article

C2 - 12850594

AN - SCOPUS:0038383852

VL - 979

SP - 245

EP - 248

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -